T1	Intervention 38 62	receptor-γ pioglitazone
T2	Intervention 487 509	(PPAR-γ) pioglitazone
T3	Intervention 820 926	trial of 45 mg daily pioglitazone versus placebo, with a 3-month duration/arm and a 2-month washout period
T4	Intervention 1453 1476	treatment, pioglitazone
T5	Intervention 1618 1630	with placebo
T6	Intervention 1632 1653	Further, pioglitazone
T7	Intervention 1804 1828	Addition of pioglitazone
